PubIndex
Search
Leaderboards
Bookmark
My Library
Sign in
Back
Cell Signaling Technology
Centrin-2 Antibody
#2091 · $317
100
Citing papers
18.9k
Combined citations
Copy product info
Export PDF dossier
Supplier page
Find this product
Research areas
Neuroinflammation and Neurodegeneration Mechanisms
8
Alzheimer's disease research and treatments
7
Autophagy in Disease and Therapy
7
Inflammasome and immune disorders
6
Cell death mechanisms and regulation
5
interferon and immune responses
5
Cancer-related gene regulation
5
Immune Cell Function and Interaction
5
Papers citing this product
1
Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease
Nature Neuroscience
·
2019
·
1.7k cit.
·
DOI
2
PPARγ and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale
Genes & Development
·
2008
·
825 cit.
·
DOI
3
The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis
Journal of Clinical Investigation
·
2005
·
696 cit.
·
DOI
4
Toll–Like Receptor 4 Mediates Inflammatory Signaling by Bacterial Lipopolysaccharide in Human Hepatic Stellate Cells
Hepatology
·
2003
·
643 cit.
·
DOI
5
Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4
Diabetes
·
2010
·
533 cit.
·
DOI
6
Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation
The Journal of Experimental Medicine
·
2005
·
494 cit.
·
DOI
7
Nuclear PTEN Controls DNA Repair and Sensitivity to Genotoxic Stress
Science
·
2013
·
410 cit.
·
DOI
8
Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma
Journal of Clinical Investigation
·
2007
·
395 cit.
·
DOI
9
Amelioration of Alzheimer’s disease pathology by mitophagy inducers identified via machine learning and a cross-species workflow
Nature Biomedical Engineering
·
2022
·
333 cit.
·
DOI
10
Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of -synuclein in Parkinson's disease models
Human Molecular Genetics
·
2013
·
325 cit.
·
DOI
Show 90 more papers
Feedback
Centrin-2 Antibody — Evidence — PubIndex